Lipocine Inc.

LPCN | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.24

+$0.03 (+1.36%)

At close: Sep 21, 2026, 4:00 PM ET

$2.24

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.36%

(1D)

Rating

Updated: Sep 12, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $18.47M

1D Range

2.18 2.24

52W Range

1.81 12.37

Valuation (TTM)

PE -1.20

PB 0.85

EV/EBITDA 0.41

Valuation (NTM)

Forward PE N/A

Forward PEG -0.19

Price Target $6

Cash Flow

FCF Yield -60.6%

SBC Adj. FCF Yield -61.8%

SBC Impact -2.1%

Margins

Gross Margin 98.1%

Operating Margin -800.8%

FCF Margin -713.0%

Growth (CAGR)

Revenue 3Y | 5Y 205.6% | -47.6%

Dil EPS 3Y | 5Y -9.4% | -26.1%

FCF 3Y | 5Y -46.2% | -6.7%

Returns

ROA -49.7%

ROE -64.8%

ROIC -57.7%

Financial Health

Net Cash

$23.27M

Current Ratio 11.48

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Lipocine Inc. is a biopharmaceutical firm currently in the clinical development phase, concentrating its efforts on creating medicinal products to address a range of neuroendocrine and metabolic condi...

Sector Healthcare

Industry Biotechnology

Employees 14

IPO Date Oct 21, 2013

Website www.lipocine.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

Upside

+167.86%

Buy (0)

Hold (1)

Sell (0)

Analyst Details ➞